These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 24853416)

  • 1. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
    Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
    Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
    Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
    J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
    Deng W; Zhang Y; Fang P; Shi H; Yang S
    Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
    Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
    Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.
    Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z
    Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
    Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T
    Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
    Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
    Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in idiopathic pulmonary fibrosis.
    Pandit KV; Milosevic J; Kaminski N
    Transl Res; 2011 Apr; 157(4):191-9. PubMed ID: 21420029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
    J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
    Jiang H; Chen Y; Yu T; Zhao X; Shan H; Sun J; Zhang L; Li X; Shan H; Liang H
    Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L563-L575. PubMed ID: 29952219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
    Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
    Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
    Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-184 targets TP63 to block idiopathic pulmonary fibrosis by inhibiting proliferation and epithelial-mesenchymal transition of airway epithelial cells.
    Li J; Pan C; Tang C; Tan W; Zhang W; Guan J
    Lab Invest; 2021 Feb; 101(2):142-154. PubMed ID: 32989231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice.
    Guan S; Liu H; Zhou J; Zhang Q; Bi H
    Toxicol Lett; 2022 Jun; 363():45-54. PubMed ID: 35472619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
    PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis.
    Weng CM; Li Q; Chen KJ; Xu CX; Deng MS; Li T; Zhang DD; Duan ZX; Chen ZQ; Li GH; Chen J; Wang JM
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Family with Sequence Similarity 13, Member A Exacerbates Pulmonary Fibrosis Potentially by Promoting Epithelial to Mesenchymal Transition.
    Rahardini EP; Ikeda K; Nugroho DB; Hirata KI; Emoto N
    Kobe J Med Sci; 2020 Jan; 65(3):E100-E109. PubMed ID: 32029695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W; Cai X; Qian Q; Zhang W; Wang D
    J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.